Literature DB >> 6855198

Lavage type III procollagen N-terminal peptides in human pulmonary fibrosis and sarcoidosis.

R B Low, K R Cutroneo, G S Davis, M S Giancola.   

Abstract

Levels of type III procollagen N-terminal peptide were immunoassayed in sera and bronchoalveolar lavage fluids from healthy volunteers and patients with idiopathic pulmonary fibrosis or sarcoidosis. Peptide levels normalized to protein were higher than corresponding serum levels in all groups, suggesting that the lung is a producer of this peptide. Levels were significantly elevated in both patient groups, suggesting increased rates of type III collagen synthesis. Values were highest in idiopathic pulmonary fibrosis samples. Correlation of peptide levels with clinical severity of disease and lavage cell profiles was poor, perhaps because the latter reflects aspects of the disease process other than that stage in which type III collagen synthesis is altered. Lavage analyses of procollagen peptides may provide an important index of altered collagen synthesis in interstitial lung disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6855198

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  17 in total

1.  Increased procollagen type III peptide in serum of rabbits exposed to diesel engine exhaust.

Authors:  T Suzuki; T Kanoh
Journal:  Bull Environ Contam Toxicol       Date:  1990-05       Impact factor: 2.151

2.  Elevated histamine content of lung lavage in human asbestosis.

Authors:  R Bégin; Y Desmarais; M Martel; R Boileau; Y Vézina; S Massé
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 3.  Lung collagen: more than scaffolding.

Authors:  G J Laurent
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

4.  Proceedings of the British Thoracic Society. 1986 winter meeting. 11-12 December 1986, London. Abstracts.

Authors: 
Journal:  Thorax       Date:  1987-03       Impact factor: 9.139

5.  Evidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosis.

Authors:  N K Harrison; R J McAnulty; P L Haslam; C M Black; G J Laurent
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

6.  Evaluation of serum type III procollagen peptide as an exposure marker in retired coal workers.

Authors:  R P Schins; R J Lamers; B Préat; P J Borm
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

7.  Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance.

Authors:  J M Kirk; E D Bateman; P L Haslam; G J Laurent; M Turner-Warwick
Journal:  Thorax       Date:  1984-10       Impact factor: 9.139

8.  Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity in farmer's lung.

Authors:  L Bjermer; A Engström-Laurent; R Lundgren; L Rosenhall; R Hällgren
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-03

9.  Transpulmonary gradient of type III procollagen peptides: acute effects of cardio-pulmonary bypass.

Authors:  N K Harrison; G J Laurent; T W Evans
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

10.  Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis.

Authors:  J Behr; B C Adelmann-Grill; F Krombach; T Beinert; M Schwaiblmair; G Fruhmann
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.